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ESCULENTOSIDE A (EsA) is a saponin isolated from the
roots of Phytolacca esculenta. Previous experiments
showed that it had strong anti-inflammatory effects.
Tumour necrosis factor (TNF) is an important inflam-
matory mediator. In order to study the mechanism of
the anti-inflammatory effect of EsA, it was determined
whether TNF production from macrophages was altered
by EsA under lipopolysaccharide (LPS) stimulated
conditions. EsA was found to decrease both extracellular
and cell associated TNF production in a dose dependent
manner at concentrations higher than I pmol/1 EsA.
Previous studies have showed that EsA reduced the
releasing of platelet activating factor (PAF) from rat
macrophages. The reducing effects of EsA on the release
ofTNF and PAF may explain its anti-inflammatory effect.
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Introduction
Esculentoside A (EsA) is a saponin isolated from
the root of Phytolacca esculenta, and is identified as:
3-O- [/g- D-- glucopyranosyl- (1 4)-/g- D-- xylo-
pyranosyl] phytolaccagenin. The structure of this
compound is shown in Fig. 1. Experiments showed
that it has strong anti-inflammatory effects. It is
now known that tumour necrosis factor (TNF)
possesses a number of properties of inflammatory
response.
2 Platelet activating factor (PAF) is also an
inflammatory mediator. 3 It has been shown that
EsA inhibited the production of PAF by A23187
stimulated rat macrophages.
4 The aim of this work
was to evaluate the effects ofEsA on the production
of TNF by LPS stimulated mice peritoneal
macrophages.
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FIG. 1. The structure of esculentoside A.
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Materials and Methods
Mice: Inbred mice C57BL/6, aged 8-10 weeks were
obtained from the Zoological Experiment Center of
the Second Military Medical University.
Reagents: RPMI-1640, calcimycin (A23187) and
lipopolysaccharide (Escherichia coli 055:B5) were
purchased from Sigma, USA. Thioglycolate was
supplied by Shanghai Biological Research Institute.
Preparation of macrophages: Thioglycolate medium
(1.5 ml, 3%) was injected i.p. into the C57BL/6
mice. Four days later, the macrophages in the
peritoneal cavity were harvested with D-Hanks
solution, washed twice in RPM1-1640, and adhered
for 2 h at 37C in a CO2 incubator, in 24-well plates
at a concentration of 1 106 macrophages/well in
1 ml RPMI-1640 with 10% foetal calf serum.
TNF production: 2 h later, the medium containing
non-adherent cells was decanted and the wells were
rinsed twice with D-Hanks and twice with
RPMI-1640. Then the adherent cells were incubated
with A23187 (1/mol/1) for 6 h. After incubation,
the medium was discarded, and the cells were
washed three times with RPMI-1640 to remove
A23187. Fresh culture medium without serum was
added to every well with lipopolysaccharide (LPS,
10 ng/ml) in presence or absence of EsA. The
cultures were incubated for another 6 h at 37C in
a CO2 incubator. The supernatants were harvested
and centrifuged. The cell-free supernatants were
collected, dialysed in PBS for 24 h, and stored at
-20C prior to activity assay. To determine the
cell associated intracellular TNF activity, the cells
remaining in the wells were covered with 1 ml of
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fresh culture medium, and frozen at -40C. After
thawing, the cells were sonicated, and the lysates
were centrifuged to remove the particles, and stored
at -20C for activity assay.
TNF production assay: TNF assay was performed
essentially as described by Kunkel with minor
modifications. Briefly, L929 cells (50 000/well) were
dispensed into 96-well flat-bottomed microtitre
plates in a volume of 0.1 ml/well. The following
day, the cells were incubated for 18 h in the presence
of 1/,g of actinomycin D and serial 1:2 dilutions
of test sample. Media were then decanted, and the
remaining cells in each well were stained with
crystal violet for about 15 min, washed with tap
water, and dried at 40C. Absorbance of the cells
in each well was read using a microenzyme linked
immunosorbent autoreader. Units of TNF activity
were defined as in Reference 5.
Cell viability: The trypan blue exclusion test was
performed after 6 h incubation with or without
EsA. Cell viability was also determined by
measuring lactate dehydrogenase (LDH) activity in
the cell-free supernatants according to the method
of Beutle.6
Results
Effects of EsA on extracellular production of TNF from
macrophages: The extracellar production of TNF in
the supernatant after being dialysed was assessed by
the killing of L929 cells. One unit of TNF was
defined as the reciprocal of the dilution of a
preparation that results in 50% survival of the cells.
The results are presented in Table 1. It is observed
Table 1. Effects of EsA on extracellular and cell associated TNF
production by 106 mice peritoneal macrophages stimulated
with 10 ng LPS. Results, expressed as units/1 106 cells, are
means ___
SD of a typical experiment
Extracel u lar ntracellu lar
(units/1 x 106 Mo) (units/1 x 106 Mo)
LPS 105.9 +_ 17.2 15.0 +_ 1.7
LPS + EsA
0.01 /mol/I 85.8 _+ 9.4 13.6 _+ 2.2
0.10/mol/I 79.4 ___
6.4 11.4 _+ 1.7
1.00 #mol/I 64.2 ___
5.6** 10.6 _+ 1.2**
10.00/mol/I 58.5 _+ 6.6** 8.7 ___
0.9**
** p < 0.05.
that the decrease ofTNF production was significant
at the concentrations of 1 and 10/mol/1 EsA.
Effects of EsA on intracellar production of TNF from
peritoneal macrophages" The results in Table 1
demonstrate, that EsA reduced not only the
extracellular production of TNF but also the
intracellular production of TNF in a dose
dependent manner. Intracellular TNF production is
lower than that of extracellular production, and the
concentration of EsA that significantly decreased
TNF production is the same.
Eects of EsA on the kinetics of extracellular and cell
associated TNF production: Peritoneal macrophages
were cultured in LPS with or without EsA, and the
supernatants were harvested at 2 h intervals.
Extracellular and intracellular TNF activity can
both be detected after 2 h exposure to LPS. Figure 2
shows that intracellular and extracellular TNF
production were both inhibited in a time dependent
manner by EsA at a concentration of 5 #mol/1.
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FIG. 2. Effect of EsA on the kinetics of TNF production in supernatants and lysates from macrophages cultures stimulated with 10 ng/ml LPS for 2, 4,
6 h, untreated ((C)), or treated (O), with 5 #mol/I of EsA. Similar results were obtained in two other independent experiments.
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Table 2. LDH activities in supernatants from
peritoneal macrophages incubated with or without
EsA
LDH activity in supernatant
(nmol NADH/min/1 x 108 cells)
Control 6.5 + 0.3
EsA
0.01 #mol/I 6.7 _+ 0.2
0.10/mol/I 6.4 + 0.1
1.00 #mol/I 6.8 0.3
10.00/mol/I 6.8 + 0.1
Effects of EsA on cellular activity: In order to eliminate
the possibility that EsA was toxic for the cells
tested, cell viability was monitored by measuring
LDH activity in the supernatant and by the trypan
blue exclusion test performed at the end of the
macrophage culture. Results of the LDH in
supernatant of adherent macrophages, cultured for
6 h with various concentrations of EsA, was not
different from that of the control, as is shown in
Table 2. Cell viability was confirmed by the trypan
blue exclusion test (data not shown).
Discussion
In this study, EsA induced a dose dependent
decrease in the extracellular and cell associated TNF
concentrations measured in the supernatant and
lysates of LPS stimulated macrophages. The
kinetics of extracellular and cell associated TNF
production were also changed.
TNF was initially identified as a factor that
appeared in the circulation of animals following the
injection of endotoxins. TNF is a product of
stimulated monocytes and macrophages, but it is
also produced by keratinocytes.
7 In addition to the
cytotoxic activities of TNF in some types of
transformed cells, recent data have shown that TNF
mediated stimulation of collagenase synthesis and
prostaglandin E2 (PgE2) production by synovial
cells,
8 and stimulated bone resorption and inhibi-
tion,
9 suggesting that TNF might be an important
mediator of inflammation. Platelet activating factor
(PAF) is a mediator of anaphylaxis and inflamma-
tion; it plays an important role in inflammation, and
there is cooperation between PAF and TNF in
inflammatory reactions.1 It has been found that
EsA reduced release ofPAF from rat macrophages.
A previous study also showed that EsA can inhibit
the inflammatory reaction induced by carrageenan.
Thus, together with the present investigation it is
suggested that the anti-inflammatory effects of EsA
could be due to its reducing effects on release of
TNF and PAF.
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